Newman Ferrara LLP Announces Corporate Governance Investigation of Innoviva, Inc. - INVA

NEW YORK--()--Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Innoviva, Inc. (“Innoviva” or the “Company”) (NASDAQ:INVA focusing on potential breaches of fiduciary duty by the Company’s Board of Directors (the “Board”).

Innoviva, headquartered in Brisbane, California, is engaged in the financial management of bio-pharmaceuticals. Newman Ferrara’s investigation focuses on decisions made by the Board, including material decisions made without shareholder approval, which significantly diminish shareholder value and do not benefit the Company. Considering the Company’s lackluster performance, it appears the Board lacks the ability to fairly assess and oversee the Company’s direction and leadership.

Current Innoviva stockholders seeking more information on this matter are invited to contact Newman Ferrara attorneys Jeffrey Norton (jnorton@nfllp.com) or Roger Sachar, Jr. (rsachar@nfllp.com) to discuss this investigation and their rights.

Newman Ferrara maintains a multifaceted practice based in New York City with attorneys specializing in complex commercial and multi-party litigation, securities fraud and shareholder litigation, consumer protection, civil rights, and real estate. For more information, please visit the firm website at www.nfllp.com.

Contacts

Newman Ferrara LLP
Jeffrey M. Norton, 212-619-5400
jnorton@nfllp.com

Release Summary

Newman Ferrara LLP Announces Corporate Governance Investigation of Innoviva, Inc.

Contacts

Newman Ferrara LLP
Jeffrey M. Norton, 212-619-5400
jnorton@nfllp.com